Khashayar Dashtipour, MD
Enriched profileAssociate Professor of Neurology and Basic Sciences; Director, Division of Movement Disorders · Loma Linda University School of Medicine
Khashayar Dashtipour is Associate Professor of Neurology and Basic Sciences; Director, Division of Movement Disorders at Loma Linda University School of Medicine. OpenAlex indexes 132 publications with 2,614 citations (h-index 29); ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 16 Oct 2026
Overview
Updated 16 Oct 2026
Khashayar Dashtipour, M.D., is Associate Professor of Neurology and Basic Sciences at Loma Linda University School of Medicine. The public record shows 132 publications with 2,614 citations (h-index 29), centered on Neurological disorders and treatments, Botulinum Toxin and Related Neurological Disorders, Parkinson's Disease Mechanisms and Treatments. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 26 companies.
- Most recent indexed publication: 2026 · Tremor and other hyperkinetic movements (New York, N.Y.)
- Top research focus: Neurological disorders and treatments
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 26 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 6 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 46.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Safety and Efficacy of Droxidopa for Fatigue in Patients With Parkinsonism
Sponsor: Loma Linda University
Industry payments
Updated 16 Oct 2026
26 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- MDD US Operations, LLCProgram year2025112 payments$162,244openpaymentsdata.cms.gov ↗
- Teva Pharmaceuticals USA, Inc.Program year202565 payments$135,491openpaymentsdata.cms.gov ↗
- Biogen, Inc.Program year202535 payments$74,938openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
90%Neuromuscular Blocker73.1%Incobotulinumtoxin a56%Onabotulinumtoxina24%Daxibotulinumtoxina-lanm20%Part B, office-administered≥33 patientsAcetylcholine Release Inhibitor16.7%Rimabotulinumtoxinb100%Part B, office-administered≥15 patients+ 1 more class in this area
Nervous system
9.6%Aromatic Amino Acid Decarboxylation Inhibitor3.1%Rytary42%Carbidopa-Levodopa42%Carbidopa-Levodopa Er15%Crexont2%Part D<11 patientsAtypical Antipsychotic1%Quetiapine Fumarate63%Nuplazid38%Part D≥45 patients+ 20 more classes in this area
Cardiovascular
0.3%alpha-Adrenergic Agonist0.1%Midodrine Hcl100%Part D≥13 patientsBeta blocker0.1%Propranolol Hcl100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- High Dose AbobotulinumtoxinA for Blepharospasm: A Case Report on the Safety and Efficacy of 500 Units of AbobotulinumtoxinA.
Tremor and other hyperkinetic movements (New York, N.Y.)
Case Report2026 - Continuous, subcutaneous apomorphine infusion for Parkinson disease motor fluctuations: Results from the phase 3, long-term, open-label United States InfusON study.
Journal of Parkinson's disease
Clinical Trial2025 - Comparative Analysis of Deutetrabenazine and Valbenazine as VMAT2 Inhibitors for Tardive Dyskinesia: A Systematic Review.
Tremor and other hyperkinetic movements (New York, N.Y.)
Review2024 - The Effect of Low Dose OnabotulinumtoxinA on Cervical Dystonia in Hypermobile Ehlers-Danlos Syndrome.
Tremor and other hyperkinetic movements (New York, N.Y.)
Case Report2021 - Pimavanserin Treatment for Parkinson's Disease Psychosis in Clinical Practice.
Parkinson's disease
Article2021
Most-cited works
by citation count (OpenAlex)- 01
- 02Diffusion, spread, and migration of botulinum toxinArticle202 citations2013
- 03Tetrabenazine for the Treatment of Hyperkinetic Movement Disorders: A Review of the LiteratureArticle182 citations2012
- 04
- 05
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/khashayar-dashtipour-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
parkinsonsassociation.org/member/khashayar-dashtipour-md-phd
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →parkinsonsassociation.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
PhD
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →parkinsonsassociation.org ↗ - Board-certified Neurologist
subspecialty in movement disorders
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →parkinsonsassociation.org ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →parkinsonsassociation.org ↗
- Member
Parkinson Study Group
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →parkinsonsassociation.org ↗ - Member
American Academy of Neurology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →parkinsonsassociation.org ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →parkinsonsassociation.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida